GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quratis Inc (XKRX:348080) » Definitions » Inventories, Finished Goods

Quratis (XKRX:348080) Inventories, Finished Goods : ₩0.0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Quratis Inventories, Finished Goods?

Quratis's annual finished goods declined from Dec. 2022 (₩188.9 Mil) to Dec. 2023 (₩33.4 Mil) and declined from Dec. 2023 (₩33.4 Mil) to Dec. 2024 (₩0.0 Mil).


Quratis Inventories, Finished Goods Historical Data

The historical data trend for Quratis's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quratis Inventories, Finished Goods Chart

Quratis Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial - - 188.93 33.38 -

Quratis Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.38 33.38 - - -

Quratis Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Quratis Business Description

Industry
Traded in Other Exchanges
N/A
Address
306, 13, Teheran-ro 64-gil, Gangnam-gu, Seoul, KOR
Quratis Inc operates as a developer of vaccines and therapies designed to treat tuberculosis. The company develops youth and adults tuberculosis vaccines, messenger ribonucleic acids, and other related immune-related vaccines.

Quratis Headlines

No Headlines